Jeffery Cauble
2020
In 2020, Jeffery Cauble earned a total compensation of $447K as Chief Financial Officer at Cesca Therapeutics, a 101% increase compared to previous year.
Compensation breakdown
| Option Awards | $203,000 |
|---|---|
| Salary | $244,000 |
| Total | $447,000 |
Cauble received $244K in salary, accounting for 55% of the total pay in 2020.
Cauble also received $203K in option awards.
Rankings
In 2020, Jeffery Cauble's compensation ranked 11,306th out of 13,090 executives tracked by ExecPay. In other words, Cauble earned more than 13.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,306 out of 13,090 | 14th |
Division Manufacturing | 4,844 out of 5,621 | 14th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 652 out of 799 | 18th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 185 out of 227 | 19th |
Industry Laboratory Apparatus and Furniture | 4 out of 5 | 20th |
Source: SEC filing on November 5, 2021.
Cauble's colleagues
We found one more compensation record of an executive who worked with Jeffery Cauble at Cesca Therapeutics in 2020.
2020
Chris Xu
Cesca Therapeutics
Chief Executive Officer
News
Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K
October 26, 2023
Cesca Therapeutics CEO Chris Xu's 2021 pay falls 63% to $748K
November 1, 2022
Cesca Therapeutics CEO Chris Xu's 2020 pay jumps 323% to $2M
November 5, 2021
Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472K
April 21, 2020